ClinicalTrials.Veeva

Menu

Assessment of Whole Body Cryotherapy in Treatment of Active Axial Spondylarthritis

P

Public Assistance-Hospitals of Marseille (AP-HM)

Status

Completed

Conditions

Spondylarthritis

Treatments

Other: cryotherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT02473315
2015- A00337-42

Details and patient eligibility

About

Whole body cryotherpy (WBC) is a well-tolerated procedure that implies patients' exposition at a temperature of approximately -110 degrees.

A considerable increase in the popularity of WBC has occurred in rheumatologic patients, despite a lack of evidences of its efficiency.

Because of its interesting anti-inflammatory properties, the investigators think that WBC could be an alternative treatment to classical NSAIDs (Non Steroidal Anti Inflammatory Drugs) and corticosteroids, in patients suffering from axial spondyloarthritis.

This is a proof of concept study.

Enrollment

36 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients suffering from axial spondyloarthritis diagnosed according to ASAS criteria, with sacroiliitis on X-rays or MRI, with active disease (BASDAI > 4/10) despite a stable treatment will be included.

Exclusion criteria

  • contra indication to cooling,
  • previous WBC treatment,
  • no social security cover

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

36 participants in 2 patient groups, including a placebo group

cryotherapy
Experimental group
Treatment:
Other: cryotherapy
light cryotherapy
Placebo Comparator group
Treatment:
Other: cryotherapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems